1. NLR, MLR, and PLR are adverse prognostic variables for sleeve lobectomy within non‐small cell lung cancer
- Author
-
Rui Han, Fan Zhang, Qian Hong, Djaferi Visar, Chang Zhan, Chenguang Zhao, Fuquan Wang, Sining Zhang, Fang Li, Jiagen Li, and Juwei Mu
- Subjects
monocyte lymphocyte ratio ,neutrophil lymphocyte ratio ,platelet lymphocyte ratio ,prognostic factor ,sleeve lobectomy ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background The goal of the research was to examine the value of peripheral blood indicators in forecasting survival and recurrence among people suffering central‐type non‐small cell lung cancer (NSCLC) undergoing sleeve lobectomy (SL). Methods Clinical information was gathered from 146 individuals suffering from NSCLC who had SL at our facility between January 2014 and May 2023. Peripheral blood neutrophil lymphocyte ratio (NLR), monocyte lymphocyte ratio (MLR), and platelet lymphocyte ratio (PLR) levels were determined by receiver operating characteristic (ROC) curve to establish the threshold points. Kaplan–Meier survival analysis was employed to evaluate the prognostic value of different groupings, and both univariate and multivariate Cox proportional hazards model (referred to as COX) were performed. Results The disease‐free survival (DFS) and overall survival (OS) cutoff values were carried out via ROC analysis. Kaplan–Meier survival analysis revealed notable differences in OS for NLR (≥2.196 vs.
- Published
- 2024
- Full Text
- View/download PDF